Matthew E Nielsen MD, MS, FACSAssistant Professor, Surgery/Urology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Matthew Nielsen, MD, MS, FACS, is a member of the integrated multidisciplinary genitourinary oncology group at the Lineberger Comprehensive Cancer Center at the University of North Carolina, where he specializes in the treatment of bladder, prostate and kidney cancer. His research in medical decision making and treatment outcomes has been funded by the American Cancer Society, the National Institutes of Health and the Agency for Healthcare Research and Quality, and he is a member of the Scientific Advisory Board for the Bladder Cancer Advocacy Network.
Recent Contributions to PracticeUpdate:
- Outcomes for Robot-Assisted Intracorporeal Orthotopic Bladder Substitution After Radical Cystectomy
- Impact of Minimally Invasive vs Open Radical Cystectomy on Perioperative Outcomes and Spending
- Oncologic, Functional, and Complications Outcomes of Robot-Assisted Radical Cystectomy With Totally Intracorporeal Neobladder Diversion
- Recent Trends in the Urology Workforce in the United States
- Complications After Robot-Assisted Radical Cystectomy